Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ross Pinkerton

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
British Journal of Haematology|October 31, 2002
Isolated parenchymal lung involvement in children with stage IV Hodgkin's disease: results of the UKCCSG HD8201 and HD9201 studiesAyad Atra, Elizabeth Higgs, Michael Capra, et al.
The Lancet. Oncology|March 1, 2008
High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trialAndrew D J Pearson, C Ross Pinkerton, Ian J Lewis, et al.
Journal of Pain and Symptom Management|December 24, 2019
Prevalence of QTc Prolongation in Patients With Advanced Cancer Receiving Palliative Care-A Cause for Concern?Janet R Hardy, Daniel Bundock, Jessica Cross, et al.
Cancer|August 28, 2003
Rasburicase (recombinant urate oxidase) for the management of hyperuricemia in patients with cancer: report of an international compassionate use studyAndré Bosly, Anne Sonet, C Ross Pinkerton, et al.
Cancer Chemotherapy and Pharmacology|April 27, 2017
Population pharmacokinetic modelling of doxorubicin and doxorubicinol in children with cancer: is there a relationship with cardiac troponin profiles?Kuhan Kunarajah, Stefanie Hennig, Ross L G Norris, et al.
Leukemia & Lymphoma|October 26, 2011
Long-term outcome for immune suppression and immune related lymphoproliferative disorder: prospective data from the United Kingdom Children's Leukaemia and Cancer Group registry 1994-2004Mary M Taj, Nedim Hadzic, Susan E Height, et al.
British Journal of Haematology|January 5, 2008
Efficacy and tolerability of high-dose methotrexate in central nervous system positive or relapsed lymphoproliferative disease following liver transplant in childrenMary M Taj, Boo Messahel, Julie Mycroft, et al.
Pediatric Blood & Cancer|January 3, 2013
Long-term follow-up of children with high-risk neuroblastoma: the ENSG5 trial experienceLucas Moreno, Sucheta J Vaidya, C Ross Pinkerton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2015
Revised International Pediatric Non-Hodgkin Lymphoma Staging SystemAngelo Rosolen, Sherrie L Perkins, C Ross Pinkerton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2015
International Pediatric Non-Hodgkin Lymphoma Response CriteriaJohn T Sandlund, R Paul Guillerman, Sherrie L Perkins, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
British Journal of Haematology|October 31, 2002
Isolated parenchymal lung involvement in children with stage IV Hodgkin's disease: results of the UKCCSG HD8201 and HD9201 studiesAyad Atra, Elizabeth Higgs, Michael Capra, et al.
The Lancet. Oncology|March 1, 2008
High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trialAndrew D J Pearson, C Ross Pinkerton, Ian J Lewis, et al.
Journal of Pain and Symptom Management|December 24, 2019
Prevalence of QTc Prolongation in Patients With Advanced Cancer Receiving Palliative Care-A Cause for Concern?Janet R Hardy, Daniel Bundock, Jessica Cross, et al.
Cancer|August 28, 2003
Rasburicase (recombinant urate oxidase) for the management of hyperuricemia in patients with cancer: report of an international compassionate use studyAndré Bosly, Anne Sonet, C Ross Pinkerton, et al.
Cancer Chemotherapy and Pharmacology|April 27, 2017
Population pharmacokinetic modelling of doxorubicin and doxorubicinol in children with cancer: is there a relationship with cardiac troponin profiles?Kuhan Kunarajah, Stefanie Hennig, Ross L G Norris, et al.
Leukemia & Lymphoma|October 26, 2011
Long-term outcome for immune suppression and immune related lymphoproliferative disorder: prospective data from the United Kingdom Children's Leukaemia and Cancer Group registry 1994-2004Mary M Taj, Nedim Hadzic, Susan E Height, et al.
British Journal of Haematology|January 5, 2008
Efficacy and tolerability of high-dose methotrexate in central nervous system positive or relapsed lymphoproliferative disease following liver transplant in childrenMary M Taj, Boo Messahel, Julie Mycroft, et al.
Pediatric Blood & Cancer|January 3, 2013
Long-term follow-up of children with high-risk neuroblastoma: the ENSG5 trial experienceLucas Moreno, Sucheta J Vaidya, C Ross Pinkerton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2015
Revised International Pediatric Non-Hodgkin Lymphoma Staging SystemAngelo Rosolen, Sherrie L Perkins, C Ross Pinkerton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2015
International Pediatric Non-Hodgkin Lymphoma Response CriteriaJohn T Sandlund, R Paul Guillerman, Sherrie L Perkins, et al.
Pageof 5